GMEX Robotics Corp

GMEX Robotics Corp (GMEX) Stock Analysis

$0.772

-0.045 (-5.80%)At close

Loading chart…
High
0.810
Open
0.795
VWAP
0.78
Volume
95.34K
Mkt Cap
—
Low
0.757
Amount
74.33K
EV/EBITDA, TTM
0.00

GMEX Robotics Corporation, formerly Fitell Corporation, is a technology company. The Company is focused on designing, manufacturing, and commercializing AI-driven robotic solutions for the consumer market, building on its foundation of expertise in fitness and health products. The Company is operating at the intersection of consumer health and advanced automation.

AI analysis of GMEX Robotics Corp (GMEX)

Sell

GMEX is not a good buy right now due to its extremely low current price of $0.77, a 5-day change of -32.25%, and a troubling RSI of 19.281 indicating oversold conditions. The company is facing significant challenges, including a staggering year-to-date change of -99.93%, which raises concerns about its financial viability.

Valuation Metrics

The current forward P/E ratio for GMEX Robotics Corp (GMEX) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

Events Timeline

2026-09-25 (ET)

20:00:00

GMEX Robotics Corp Trading Halted, News Pending

2026-09-23 (ET)

17:00:00

GMEX Robotics Announces Share Consolidation and Par Value Adjustment

2026-07-28 (ET)

09:30:00

GMEX Robotics Enters Share Purchase Agreement with Alpha Meta AI

2026-07-14 (ET)

09:30:00

GMEX Robotics Signs Letter of Intent for Acquisition

2026-07-06 (ET)

09:00:00

GMEX Robotics Signs LOI to Acquire Equity Interest in California Company

News

GMEX FAQ — answered by Alphio AI

GMEX Robotics Corporation, formerly Fitell Corporation, is a technology company. The Company is focused on designing, manufacturing, and commercializing AI-driven robotic solutions for the consumer market, building on its foundation of expertise in fitness and health products. The Company is operating at the intersection of consumer health and advanced automation. It operates in the Consumer Cyclicals sector.

GMEX is not a good buy right now due to its extremely low current price of $0.77, a 5-day change of -32.25%, and a troubling RSI of 19.281 indicating oversold conditions. The company is facing significant challenges, including a staggering year-to-date change of -99.93%, which raises concerns about its financial viability.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading